Lynwood Capital Management Inc. - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 24 filers reported holding LANTERN PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
Lynwood Capital Management Inc. ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q4 2022$73
-100.0%
12,000
-76.0%
0.09%
-77.0%
Q4 2021$399,00050,0000.38%
Other shareholders
LANTERN PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 336,425$2,574,0000.44%
Lynwood Capital Management Inc. 50,000$399,0000.38%
WOLFF WIESE MAGANA LLC 34,135$272,0000.18%
Redmond Asset Management, LLC 49,187$393,0000.11%
CARLSON CAPITAL L P 125,000$998,0000.06%
Anson Funds Management LP 64,999$519,0000.05%
NewEdge Advisors, LLC 167,106$1,334,0000.02%
Trexquant Investment LP 27,970$223,0000.01%
Jump Financial, LLC 11,028$88,0000.01%
Sigma Planning Corp 17,600$140,0000.00%
View complete list of LANTERN PHARMA INC shareholders